Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides

NeuroImmunoModulation

Volumn 3, Issue 5, 1996, Pages 259-284

  Tatro, Jeffrey B ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ACTH; Agouti; Brain; Fever; Melanocortin receptor; Melanocyte; Melanocyte stimulating hormone; Neuroimmunomodulation; Receptor antagonist

Indexed keywords

ADENYLATE CYCLASE; CORTICOTROPIN; INTERMEDIN; INTERMEDIN DERIVATIVE; NEUROPEPTIDE; NEUROTRANSMITTER RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; FEVER; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0004062089     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000097281     Document Type: Article

References (224)

1. Catania A. Upton JM: α-Meianocyte stimulating hormone in the modulation of host reactions. Endocr Rev 1993:14:564-576.
2. DeWied D. Jolles J: Neuropeptides derived from pro-opiocortin: Behavioral, physiological and ncurochemical effects. Physiol Rev 1952; 62:976-1059.
3. O'Donohue TL. Dorsa DM: The opiomelano-tropinergic neuronal and endocrine systems. Peptides 1982.3:353-395.
4. Tatro JB. Rcichlin S: Specific receptors for u-melanocylc-slimulating hormone are widely distributed in tissues of rodents. Endoerinolouv 1987:121:1900-1907.
5. Tatro JB: Melanotropin receptors in the brain are differentially distributed and recognize both corticotropin and u-melanocyte stimulating hormone. Brain Res 1990:536:124-132.
6. Low MJ. Simcrly RB. Cone RD: Receptors for the mclnnoconin peptides in the central nervous system. CurrOp Endocrinol Diab 1994:1: 79-88.
7. Hoi EM. Gispen WH. Bar PR: ACTH-related peptides: Receptors and signal transduction systems involved in their neurotrophic and neuroprotective actions. Peptides 1995:16: 979-993.
8. Cone RD, Mountjoy KG, Robbins LS, Nadeau JH, Johnson KR, Roselli-Rehfuss L, Morlrud MT: Cloning and functional characterization of a family of receptors for the melanotropie peptides. Ann N V Acad Sci 1993:680:342-363.
9. Chhajlani V. Muccniccc R. Wikbcrg JF.S: Molecular cloning of a novel human melanocortin receptor. Biochem Biophys Res Commun 1993:195:866-873.
10. Gantz I. Kondaf Y. Tashiro T. Shimoto Y. Miwa H. Munzert G. Watson SJ. DclVallc J. Yamada T: Molecular cloning of a novel melanocortin receptor. J Biol Chcm 1993:268: 8248-8250.
11. Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, Watson SJ, DelValle J, Yamada T: Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chcm 1993:268:15174-15179.
12. Gantz I, Shimoto Y, Konda Y, Miwa H, Dickinson CJ, Yamada T: Molecular cloning, expression. and characterization of a fifth melanocortin receptor. Biochcm Biophys Res Commun 1994:200:1214-1220.
13. Roselli-Rehfuss L. Mountjoy KG. Robbins LS. Mortrud MT. Low MJ. Tatro JB. Entwistle ML. Simcrly RB. Cone RD: Identification of a receptor for POMC peptides in the medial basal hypothalamus and limbic system. Proc Natl Acad Sci USA 1993:90:8856-8860.
14. Catania A, Upton JM: The neuropeptide alphα-melanocyte-stimulating hormone: A key component of ncuroimmunomodulation. Neu-roimmunomodulation 1994; 1:93-99.
15. Lipton JM. G. C. Macaluso A. McCoy D. Carnes K. Billz J. Catania A: Antiinflammatory effects of the neuropeptide alphα-MSH in acute, chronic, and systemic inflammation. Ann N Y Acad Sci 1994:741:137-148.
16. Lipton JM. Glyn JR. Zimmer JA: ACTH and alphα-melanotropin in central temperature control. l ed Proc 1981:40:2760-2764.
17. Huang Q-H, Entwistle ML, Alvaro JD, Durnan RS, Hrubv VJ, Tatro JB: Antipyretic role of endogenous melanocortins mediated by central melanocortin receptors during endotoxin-induced fever. J Neurosci. in press.
18. Cannon JG. Tatro JB. Rcichlin SR. Dinarello CA: α-Mclanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin-1. J Immunol 1986:137: 2232-2236.
19. Bhardwaj RS. Schwarz A. Becher E. Malmke K. Aragane Y. Schwarz T. Luger TA: Proopiomelanocortin-derived peptides induce IE-10 production in human monocytes. J Immunol 1996:156:2517-2521.
20. Smith F.M, Brosnan P, Meyer WJ, Blalock JE: An ACTH receptor on human mononuclear leukocytes. N Engl J Med 1987:317:1266-1269.
21. Star RA. Rajora N. Huang J. Stock RC. Catania A. Lipton JM: Evidence of autocrine modulation of macrophage nitric oxide synthase by α-melanocyte-stimulaling-hormonc. Proc Natl Acad Sci USA 1995:92:8016-8020.
22. Smith EM. Hughes TKJ. Hashemi F. Stcfano GB: Immunosuppressive effects of corticotropin and melanotropin and their possible significance in human immunodeficiency virus infection. Proc Natl Acad Sci USA 1992:89:782-786.
23. Duvaux-Mirct O. Stelano GB. Smith EM. Dissous C. Capron A: Immunosuppression in the definitive and intermediate hosts of the human parasite Schistosoma mansoni by release of im-munoactivc neuropeptides. Proc Natl Acad Set USA 1992:89:778-781.
24. Gencdani S. Beroardi M. Ollaviani E. Eranccs-chi C. Leung MK. Stefano GB: Differential modulation of invertebrate hemocyte motility by CRF. ACTH. and its fragments. Peptides 1994:15:203-206.
25. Dayncs RA. Robertson BA. Clio B-H. Burnham DK. Newton R: α-Melanocytc-stimulating hormone exhibits target cell selectivity in its capacity to affect interleukin I-inducible responses in vivo and in vitro. J Immunol 1987; 139:103-109.
26. Munck A. Guyre PM. Holbrook NJ: Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. En-docr Rev 1984:5:25-44.
27. Rcichlin S: Neuroendocrine-immune interactions. N Engl J Med 1993:329:1246-1253.
28. Calogero AE. Gallucci WT, Gold PW, Chrou-sos GP: Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion: Potential clinical implications. J Clin Invest 1988:82:767-774.
29. Rivier C, Chizzonite R, Vale W: In the mouse, the activation of the hypothalamie-pituitarγ-adrcnal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. Endocrinology 1989:125:2800-2805.
30. Lyson K. McCann SM: Alphα-melanocyte-stimulating hormone abolishes IL-l-and IL-6-induccd corticotropin-releasing factor release from the hypothalamus in vitro. Neuroendocrinology 1993:58:191-195.
31. Zelazowski P. Patchcv VK. Zclazowska F.B. Chrousos GP. Gold PW. Sternberg EM. Release of hypothalamic corticotropin-releasing hormone and arginine-vasoprcssin hy interleukin 11 and uMSH: Studies in rats with different susceptibility to inflammatory disease. Brain Res 1993:631:22-26.
32. Tozawa E. Suda T. Dobashi I. Ohniori N. Kas-agi Y. Demura H: Central administration of u-melanocyte-stimulatiug hormone inhibits corticotropin-releasing factor release in adrcnaleo-tomized rats. Neurosci Lett 1994:174: J17-119.
33. Bowers CY. Redding TW. Schallv AV: Effects ol u- and i- melanocyte stimulating hormones and other peptides on the thyroid in mice. Endocrinology 1964:74:559.
34. Zahnd GR. Vecsey A: Stimulation of growth hormone release in vivo and in vitro Ivy u-MSH. Front Horm Res 1977;4:188-192.
35. Khorram O. DePalatis R. McCann SM: The effect and possible mode of action of u-melano-cyte-stimulating hormone on gonadotropin release in the ovaricelomizcd rat: An in vivo and in vitro analysis. Endocrinology 1984:114. 227-233.
36. Ellcrkmann E. Nagy GM. Frawlcy LS: α-Mcla-nocyte-stimulating hormone is a mammo-trophic factor released by ncuroiniermediale lobe cells after estrogen treatment. Endocrinology 1992:130:133-138.
37. Luger TA, Schaucr E, Trauiingcr F, Krutmann J, Ansel J, Sclnvarz A, Schwarz T: Production of immunosuppressing melanotropins by human keralinocylcs. Ann NY Acad Sci 1993: 650:567-570.
38. Chiao H, Foster S, Thomas Rilipton JM, Star RA: α-Melanocytc-stimulating hormone reduces endotoxin-induced liver inflammation. J Clin Invest 1996,97:2038-2044.
39. Weiss JM. Sundar SK. Cicrpial MA. Ritchie JC: Effects of interleukin-1 infused into brain arc antagonized by α-MSH in a dose-dependent manner. F.ur J Pharmacol 1991:192:177-179.
40. Sundar SK, Becker KJ, Cierpial MA, Carpenter MD, Rankin LA, Fleener SL, Ritchie JC, Sim-son PE, Weiss JM: Intraccrcbroventricular infusion of interleukin I rapidly decreases peripheral cellular immune responses. Proc Natl Acad Sci USA 1989;86:6398-6402.
41. Sundar SK. Cicrpial MA. Kamaraju LS. Long S. Hsich S. Lorenz C. Aaron M. Ritchie JC. Weiss JM: Human immunodeficiency virus glycoprotein (gp!20) infused into rat brain induces interleukin 1 to elevate pituitarγ-adrenal activity and decrease peripheral cellular immune responses. Proc Natl Acad Sci USA 1991:88:11246-11250.
42. Shalts E. Feng Γ-J. Fcrin M. Wardlaw SL: alphα-Melanocytc-stimulating hormone antagonizes the neuroendocrine effects of corticotropin-releasing factor and interleukin-1-alpha in the primate. Endocrinology 1992:131:132-138.
43. Farrar WL. Kalian PL. Ruff MR. Hilt JM. Pen CB: Characterization of interleukin 1 receptors in brain. J Immunol 1987:139:459-463.
44. Eberle A: The Melanotropins. Basel. Karger. 1958.
45. Wong G. Pawclck J: Control of phenotypic expression of cultured melanoma cells by melanocyte stimulating hormones. Nature New Biol 1973:241:213-216.
46. Hofmann K: Relations between chemical structure and function of adreno-conicotropin and melanocyte-stimulating hormones: in Knobil E. Sawyer Wll (eds): Handbook of Physiology. Washington. American Physiological Society. 1974, pp 29-58.
47. Klcmckc HG. Pond WG: Porcine adrenal adrenocorticotropic hormone receptors: Characterization. changes during neonatal development, and response to a stressor. Endocrinology 1990; 128:2476-2488.
48. Howard CB, Yang YCS, Sawyer TK, Bregman MD, Fuller BB, Hrubv VJ, Hadley ME: lodin-ation-associated inactivation of p-mclanocytc stimulating hormone. Biochem Biopitys Res Commun 1979:88:266-273.
49. 4.D-Phc’]α-mclanocytc stimulating hormone: A highly potent α-melanotropin with ultralong biological activity. Proc Natl Acad Sci USA 1980:77:5754-5758.
50. Lambert DT. Stachclck C. Varga JM. Lemer AB: lodinationof[1-melanotropin. J BiolChcm 1982;257:8211-8215.
51. Gersl JE. Sole J. Mather JP. Salomon Y: Regulation of adenylate cyclase by betα-melanotro-pin in the MR2 melanoma cell line. Mol Cell Endocrinol 1986:46:137-147.
52. lNH; with the FI variant of B16 melanoma cells. J Cell Physiol 1987;132:97-103.
53. Sicgrist W. Solca F. Stulz S, GiulTrc L, Carrel S, Girard J, Eberle AN: Characterization of receptors for u-mclanocyte stimulating hormone on human melanoma cells. Cancer Res 1989;49:6352-6358.
54. J.0-Phc]-α-MSH at the mclano-cortin-l receptor. Biochem Biophys Res Commun 1995:202:1266-1271.
55. Tatro JB. Entwistle ML. Lester BR. Reichlin S: Mclanotropin receptors of murine melanoma characterized in cultured cells and demonstrated in experimental tumors in situ. Cancer Res 1990;50:1237-1242.
56. Haskcll-Leuvano C, Miwa H, Dickinson C, Hadley ME, Hruby VJ, Yamada T, Gantz I: Characterizations of the unusual dissociation properties of mclanotropin peptides from the melanocorlin receptor. ItMClR. J Med Client 1996:39:432-435.
57. Abdcl-Malck Z. Krcutzfcld KL. Marwan MM. Hadley ME. Hruby VJ. Wilkes BC: Prolonged stimulation of S91 melanoma tyrosinase by substituted o-melanotropins. Cancct Res 1985; 45:4735-4740.
58. Chaturvcdi ON. Knittcl JJ. IIruby VJ. Castruc-ci AML. Hadley ME: Synthesis and biological actions of highly potent and prolonged acting biotin-labeled melanotropins. J Med Chcm 1984:27:1406-1410.
59. Eberle AN: Peptides containing multiple pho-tolabcls: A new tool for the analysis of ligand-reccptor interactions. J Reccpt Res 1993:13: 27-37.
60. Hann LE. Tatro JB. Sullivan DA: Morphology and function of lacrimal gland acinar cells in primary culture. Invest Ophthalmol Vis Sci 1989:30:145-158.
61. Entwistle ML. Hann LE. Sullivan DA. Tatro JB: Characterization of functional mclanotropin receptors in lacrimal glands of the rat. Peptides 1990:11:477-483.
62. Jahn R. Padcl U. Porsch PH. Soling HD: Adrenocorticotropic hormone and α-melanocytc-stimulating hormone induce secretion and protein phosphorylation in the rat lacrimal gland by activation of a cAMP-dcpcndcnt pathway. EurJ Biochem 1982:126:623-629.
63. Leiba H. Garty NB. Schmidt-Sole J. Pitcrman O. Azrad A. Salomon Y: The mclanocortin receptor in the rat lacrimal gland: A model system for the study of MSH (melanocyte stimulating hormone) as a potential neurotransmitter. EurJ Pharmacol 1990;181:71-82.
64. Tatro JB. Entwistle ML: Heterogeneity of brain mclanocortin receptors suggested by differential ligand binding in situ. Brain Res 1994: 635:148-158.
65. Griffon N. Mignon V. Facchinclti P. Diaz J. Schwartz J. Sokoloff P: Molecular cloning and characterization of the rat fifth mclanocortin receptor. Biochem Biophys Res Commun 1994:200:1007-1014.
66. Tatro JB: Mclanotropin receptors of the brain; in Conn PM (ed): Methods in Ncuroscienccs. New York, Academic Press. 1993. pp 87-104.
67. Tatro JB. Entwistle ML: Distribution of melα-nocortin receptors in the lower brainstem of the rat. Ann NY Acad Sci 1994:739:311-314.
68. Lichtcnsteigcr W, Hanimann B, Sicgrist W, Eberle AN: Region- and stage-specific patterns of mclanocortin receptor ontogeny in rat central nervous system, cranial nerve ganglia and sympathetic ganglia. Dev Brain Res 1996:91: 93-110.
69. Alvaro JD. Tatro JB. Quillan JM. Fogliano M. Eisenhard M. Lcrner MR, Nestler EJ, Duman RS: Morphine down-regulales melanocortin-4 receptor expression in brain regions that mediate opiate addiction. Mol Pharmacol 1996; 50:583-591.
70. De Wild! DJ. Van Der Ven JC. Van Bergen P. De Lang H. Verstecg DUG: A hypotensive and bradycardic action of y2-melanocyte-siimulat-ing hormone (y2-MSH) microinjected into the nucleus tractus solitarii of the rat. Arch Pharmacol 1994;349:50-56.
71. O'Donohuc TL. Miller RL. Jacobowitz DM: Identification, characterization and stereotaxic mapping of intrancuronal u-mclanocytc stimulating hormone-like immunorcactivc peptides in discrete regions of the rat brain. Brain Res 1979:176:101-123.
72. Lit S-J, Varga K, Archer P, Hruby VJ, Sharma SD, Kestcrson RA, Cone RD, Kunos G: Mclα-nocortin antagonists define two distinct pathways of cardiovascular control by n- and γ-mclanocyte-stimulating hormones. J Neurosci 1996:16:5182-5188.
73. Tatro JB: Brain receptors for central and peripheral melanotropins. Ann N Y Acad Sci 1993:680:621-625.
74. Wilson JF: Low permeability of the blood-brain barrier to nanomolar concentrations of immunorcactivc alpha-mdanotropin. Psychopharmacology (Berl) 1988;96:262-266.
75. Van Houten M, Khan MN, Walsh RJ, Baqui-ran GB, Renaud LP, Bourque C, Sgro S, Gauthier S, Chretien M, Posner BI: NHi-tcrminal specificity and axonal localization of adrcno-corticotropin binding sites in rat median eminence. Proc Natl Acad Sci USA 1985:82:1271-1275.
76. Adan RAH. Cone RD. Burbach PH. Gispcn WH: Differential effects of mclanocortin peptides on neural mclanocortin receptors. Mol Pharmacol 1994:46:1182-1190.
77. Miwa H, Gantz I, Konda Y, Shimoto Y, Yamada T: Structural determinants of the mclanocortin peptides required for activation of mclanocortin-3 and mclanocorlin-4 receptors. J Pharmacol ExpThcrap 1995:273:367-372.
78. Schiolh HB. Muceniece R. Wikbcrg JES. Chhajlani V: Characterisation of mclanocortin receptor subtypes by radioligand binding analysis. EurJ Pharmacol 1995:288:311-317.
79. j]ACTH.;4 in homogenatcs and slices from rat brain. Can J Physiol Pharmacol 1989: 67:568-576.
80. Li Z. Queen G. LaBella FS: Adrenocorticotro-pin. vasoactive intestinal polypeptide, growth hormone-releasing factor, and dynorphin compete for common receptors in brain and adrenal. Endocrinology 1990:126:1327-1333.
81. Florijn WJ, Dc Boer T, Tonnacr JADM. Van Nispen JW, Verstecg DHG: ACTH/MSH-like peptides inhibit the binding of dopaminergic ligands to the dopamine D2 receptor in vitro. EurJ Pharmacol 1991:207:43-50.
82. Pranzatelli MR: On the molecular mechanism of adrcnocorticotrophic hormone in the CNS: neurotransmitters and receptors. Exp Neurol 1994;125:142-161.
83. Kobobun K, O'Donohue TL, Handelnian GE, Sawyer TK, Hruby VJ, Hadley ME: Behavorial effects of [4-norleucinc. 7-D*phenylalanine]-α-melanocyte-stimulating hormone. Peptides 1983;4:721-724.
84. Tatro JB, Atkins M, Micr JVV, Hardarson S, Wolfe H, Smith T, Enlwistlc ML, Rcichlin S: Melanotropin receptors demonstrated in situ in human melanoma. J Clin Invest 1990:85: 1825-1832.
85. O'Donohue TL, Ilanddman GE, Loh YP, Ol-ton DS, Lcibowitz J, Jacobowiu DM: Comparison of biological and behavioral activities of α-and γ-mclanocytc stimulating hormones. Peptides I9S 1:2:101-104.
86. Van Ree JM. Bohus B. Csontos KM. Gispen WH. Greven HM: Behavioral profile of γ-MSH: relationship with ACTH and β-endorphin action, Life Sei 1981:28:2875-2888.
87. Mountjoy K. Robbins LS. Mortrud. MT. Cone RD: The cloning of a family of genes that encode the mclanocortin receptors. Science 1992;257:1248-1251.
88. Chhajlani V. Wikbcrg JES: Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett 1992:309:417-420.
89. Alvaro JD, Nestler EJ, Duman RS: Isolation of mclanocortin receptor cDNAs from locus ccru-leus and ventral tegmentum by PCR. Soc Neu-rosci Abstr 1993:19:1542.
90. Fathi Z. lbcn LG. Parker EM: Cloning, expression. and tissue distribution of a fifth mclano-cortin receptor subtype. Ncurochcm Res 1995: 20:107-113.
91. Camillas FM, Kapas S, Barker Sm Clark AJL: Cloning, characterization and expression of a functional mouse ACTH receptor. Biochcm Biophys RcsCommun 1995:212:912-918.
92. Vanctli M. Schonrock C. Meyerhof W. Holli V: Molecular cloning of a bovine MSH receptor which is highly expressed in the testis. FEBS Lett 1994:348:268-272.
93. Kubo M. Ishizuka T. Kijima H. Kakinuma M. Koike T: Cloning of a mouse ad re nocorticotropin receptor-encoding gene. Gene 1995; 153: 279-280.
94. Raikhinstein M, Zohar VI, Hanukoglu I: cDNA cloning and sequence analysis of the bovine adrenocorticotropic hormone (ACTH) receptor. Biochim Biophys Acta 1994;1220:329-332.
95. Barrett P. MacDonald A. Helliwell R. Davidson G. Morgan P: Cloning and expression of a new member of the melanocyte-stimulating hormone receptor family. J Mol Endocrinol 1994:12:203-213.
96. Probst WC. Snyder LA. Schuster DI. Brosius J. Sealfon SC: Sequence alignment of the G-pro-tcin coupled receptor superfamily. DNA Cell Biol 1992;11:1-20.
97. Solca F, Sicgrist W, Drodz R, Girard J, Ebcrlc AN: The receptor for n-melanotropin of mouse and human melanoma cells: Application of a potent phoioaffinity label. J Biol Chcm 1989:264:14277-14281.
98. Desarnaud F. Labbc O. Eggcrickx D. Vassar G. Parmcntier M: Molecular cloning, functional expression and pharmacological characterization of a mouse mclanocortin receptor gene. Biochcm J 1994:299:367-373.
99. Labbii O. Desarnaud F. Eggcrickx D. Vassart G. Parmcntier M: Molecular cloning of mouse mclanocortin 5 receptor gene widely expressed in peripheral tissues. Biochemistry 1994:33:4543-4549.
100. llausdorff WP, Caron MG, Lefkowitz RJ: Turning off the signal: Desensilization of b-adrencrgic receptor function. FASEB J 1990: 4:2881-2889.
101. Lefkowitz RJ: G protein-coupled receptor kinases. Cell 1993:74:409-412.
102. Lande S. Pawclek J. Lerner AB. Emanuel JR: Assay of melanotropic peptides in an in vitro mammalian system. J Invest Dermatol 1981: 77:244-248.
103. Tamale HB. Takeuchi T: Action of thee locus of mice in the response of phcomclanic hair follicles to alphα-mclanocytc-stimulating hormone in vitro. Science 1984:24:1241-1242.
104. Robbins LS. Nadeau Jll, Johnson KR, Kelly MA, Rosclli-Rchfuss L, Baack E, Mountjoy KG, Cone RD: Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 1993:72:827-834.
105. Silvers WK: The Coat Colors of Mice. New York. Springer. 1979.
106. Xia Y. Wikbcrg JES, Chhajlani V: Expression of mclanocortin I receptor in periaqueductal gray matter. Neuroreport 1995:6:2193-2196.
107. Rajora N. Ccriani G. Catania A. Star RA. Murphy MT. Lipton JM: u-MSH. receptors, and influence on neoptcrin in a human monocyte/macrophage cell line. J Leukocyte Biol 1996:59:248-253.
108. Tairo JB, Wen Z, Emwistle ML, Atkins MB, Smith TJ, Rcichlin S, Murphy JR: Interaction of an u-melanocyte stimulating hormonc-diphtheria toxin fusion protein with mclano-tropin receptors in human melanoma mclas-lases. Cancer Res 1992:52:2545-2548.
109. Hunt G: Melanocyte-stimulating hormone: A regulator of human melanocyte physiology. Pathobiology 1995:63:12-21.
110. Mountjoy KG: The human melanocyte stimulating hormone receptor has evolved to become 'super-sensitive' to melanocorlin peptides. Mol Cell Endocrinol 1994;I02:R7-R11.
111. Tbody AJ, Fisher C, Kendal-Taylor P, Jones MT, Price J, Abraham RR: The measurement and characterization by high pressure liquid chromatography of immunoreactive u-mela- nocyle stimulating hormone in human plasma. Acta Endocrinol (Copenh) 1985:110: 313-318.
112. Kortlandt W. de Rotte AA. Arts CJM. Croughs RJM. Thijssen JHH: Characterization of α-MSH-like immunoreactivity in human plasma. Acta Endocrinol (Copenh) 1986;113:175-180.
113. Spiro J. Parker S. Oliver I. Fraser C. Marks JM. Thody AJ: Effect of PUVA on plasma and skin immunoreactive α-mclanocyte stimulating hormone concentrations. BrJ Dermatol 1987:117:703-707.
114. Colao A. Merola B. Cataldi M. La Tessa G. Boudourcsque F. Oliver C. di Renzo G. Annunziato L. Lombardi G: Alphα-melanocyte-slimulating hormone is present in the inferior petrosal sinuses in patients with Cushing's disease. Ncurocndocrinologv 1993:58:227-233.
115. Limone P, D'Alessandro V, Rainero I, Ambrogio C, Pincssi L, De Gennaro T, Molinai! GM: Adrenergic regulation of α-MSH secretion in man: Evidence for a stimulatory role of p-rcccptors. Acta Endocrinol (Copenh) 1993:128:150-155.
116. Evans VR. Manning AB. Bernard LH, Chron-wall BM, Millington WR:α-Mclanocytc-stim-ulating hormone and N-acetyl-p-cndorphin immunoreaclivitics are localized in the human pituitary but are not restricted to the zona intermedia. Endocrinology 1994:134: 97-106.
117. Hadley ME: Endocrinology. Upper Saddle River. Prentice-Hall, 1996.
118. Liu MA. Nussbaum SR. Eisen HN: Hormone conjugated with antibody to CD3 mediates cytotoxic T ceil lysis of human melanoma cells. Science 1988:239:395.
119. 485 results in the formation of a highly potent fusion toxin which is resistant to proteolytic degradation. J Biol Client 1991:266:12289-12293.
120. Schwyzcr R. Kriwaczck VM. Wundcrlin R: A method for mapping peptide receptors. Nα-turwisscnschaften 1981:68:95-96.
121. Wraight F.P, Bard DR, Maughan TS, Knight CG, Page-Thomas DP: The use of a chelating derivative of alpha melanocyte stimulating hormone for the clinical imaging of malignant melanoma. Brit J Radiol 1992:65:112-118.
122. Cammas FM. Clark AJL: Gene structure and mRNA tissue distribution of the mouse ACTH receptor gene. Progr 10th Int Congr Endocrinol 1996:203.
123. Boston BA. Cone RD: Characterization of mclanocortin receptor subty pe expression in murine adipose tissues and in the 3T3-LI cell line. Endocrinology 1996;137:2043-2050.
124. White JE, Engel FL: Lipolytic action of corticotropin on rat adipose tissue in vitro. J Clin Invest 1958.37:1556-1563.
125. Rabcn MS. Landolt R. Smith FA. Hofmann K, Yajima H: Adipokinetic activity of synthetic peptides related to corticotropin. Nature 1961:189.
126. Weber A, Toppari J, Hanev RD, Klann RC, Shaw NJ, Ricker AT, Nanto-Salonen K, llevan JS, Clark AJL: Adrenocorlicotropin re-eeptor gene tnuialions in familial glucocorticoid deficiency; Relationships with clinical features in four families. J Clin Endocrinol Mctab 1994;80:65-71.
127. Tsigos C, Arai K, Hung W, Chrousos GP: Hereditary isolated glucocorticoid deficiency is associated with abnormalities of the adrc-nocorticotropin receptor gene. J Clin Invest 1993:92:2458-2461.
128. Tsigos C, Arai K, Latronico AC. DiGeorge AM. Rapaport R. Chrousos GP: A novel mutation of the adrenocorticotropin receptor (ACTH-R) gene in a family with the syndrome of isolated glucocorticoid deficiency, but no ACTH-R abnormalities in two families with the triple A syndrome. J Clin Endocrinol Mctab 1995:80:2186-2189.
129. Weber A, Kapas S, Hinson J, Grant DB, Grossman A, Clark AJL: Functional characterization of the cloned human ACT1I receptor: Impaired responsiveness of a mutant receptor in familial glucocorticoid deficiency. Biochem Biophys Res Commun 1993:197: 172-178.
130. Clark AJL. Weber A: Molecular insights into inherited ACTH resistance syndromes. Trends Endocrinol Mctab 1994:5:209-214.
131. Mountjov KG, Mortmd MT, Low MJ, Simcr-Iv RB, Cone RD: Localization of the mclano-cortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 1994:8:1298-1308.
132. Van Calker D. Loffier F, Hamprechl B: Corticotropin peptides and melanotropins elevate the level of adenosine 3':5'-cyclic monophosphate in cultured murine brain cells. J Ncuro-chcm 1983:40:418-427.
133. Cholcwinski AJ. Wilkin GP: Astrocytes from forebrain, cerebellum, and spinal cord differ in their responses to vasoactive intestinal peptide. J Ncurochem 1988:51:1626-1633.
134. Zohar M. Salomon Y: Melanocortins stimulate proliferation and induce morphological changes in cultured rat astrocytes by distinct transducing mechanisms. Brain Res 1992; 576:49-58.
135. Adan RAH. van dcr Kraan M. Doomgos RP. Bar PR. Burbach JPII, Gispcn WH: Melano-cortin receptors mediate α-MSH-induccd stimulation of neuritc outgrowth in Neuro 2A cells. Mol Brain Res 1996:36:37-44.
136. Doré B. Entwistle ML. Tatro JB. Drouin J. Rosclli-Rehfuss L: Mutations in three amino acids of the rat mclanocortin 3 receptor result in altered receptor activity. Proc 10th Int Congr Endocrinol 1996, 794.
137. Valverde P. Mealy E. Jackson I. Rees JL. Tho-dy AJ: Variants of the melanocyte-stimulating hormone receptor gone are associated with red hair and fair skin in humans. Nature Genet 1995:11:328-330.
138. Prusis P, Friindberg PA, Muceniece R, Kal-vinsh I, Wikberg JES: A three dimensional model for ihe interaction of MSH with the mclanocortin-1 receptor. Biochem Biophys Res Commun 1995:210:205-210.
139. Savarcsc TM. Fraser CM: In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. Biochem J 1992:283:1-19.
140. Konda Y. Gantz I. Del Valle J. Shimolo Y. Miwa H. Yamada T: Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. J Biol Client 1994:269:13162-13166.
141. Bul'fey J. Thody AJ. Blcchcn SS. MacNeil S: u-Melanocvtc-stimulaling hormone stimulates protein kinase C activity in murine BI6 melanoma. J Endocrinol 1992:133:333-340.
142. Farcsc RV. Rosie N. Babischkin J. Foster R. Davis JD: Dual activation of the inositol-tri-phosphale-calcium and cyclic nucleotide intracellular signaling systems by adrenocorticotropin in rat adrenal cells. Biochem Biophys Res Comntun 1986:135:742-748.
143. Vcscly DL. Hadley ME: Calcium requirement for mclanophorc-stimulating hormone action on mclanophores. Science 1971:173: 923-925.
144. Lcfkowitz RJ. Roth J. Pastan 1: Effects of calcium on ACTH stimulation of the adrenal: separation of hormone binding from adcnyl cyclase activation. Nature 1970:228:864-866.
145. Cheillin R. Buckley Dl. Ramachandran J: The role of extracellular calcium in corticotropin-stimulated steroidogenesis. J Biol Chcnt 1985:260:5323-5327.
146. Tatro JB, Entwistle ML: Dual roles of calcium in neural melanocortin receptor function. Proc 10th Int Congr Endocrinol 1996: 443
147. Salomon Y: Ca' requirement of MSH-rcccp-tor function: An unusual example among G-protein-associated peptide hormone receptors. Horm Cell Regul 19S9:198:15-20.
148. Salomon Y, Zohar M, Dejordy LO, Eshcl Y, Shafir I, Leiba H, Gartv NB, Schmidt-Sole J, Azrad A, Shai E, Decani H: Signaling mechanisms controlled by melanocortins in melanoma. lacrimal, and brain astroglial cells. Ann NY Acad Sci 1993:680:364-380.
149. Mousli M. Bueb J-L. Bronncr C. Rouol B. Laradry Y: G protein activation: A receptor-independent mode of action for cationic am-phiphilic neuropeptides and venom peptides. Trends Pharmacol Sci 1990:11:358-362.
150. Lymangrovcr JR, Matthews K, Saffran M: Membrane potential changes of mouse adrenal zona fasciculata cells in response to adre-nocorlicotropin and adenosine 3'.5'-mono-phosphatc. Endocrinology 1982:110:462-468.
151. Coyne MD. Pinkney L: Adrenocorticotropin activates harium-conducting channels from bovine adrenocortical zona fasciculata cells in lipid bilayers. Endocrinology 1991:129:263-269.
152. − channels are required for adrenocortico-tropin-stimulatcd cortisol production by bovine adrenal zona fasciculata cells. Mol Endocrinol 1993:7:1031-1040.
153. Clarke BL. Moore DR. Blalock JE: Adrenocorticotropic hormone stimulates a transient calcium uptake in rat lymphocytes. Endocrinology 1994:135:1780.
154. Dcgani H. DeJordy JO. Salomon Y: Stimulation of cAMP and phosphomonocster production by mclanotropin in melanoma cells: "P NMR studies. Proc Natl Acad Sci USA 1991:88:1506-1510.
155. Jolles J, Wiegant VM, Gispcn WH: Inhibition of behavioral effect of ACTH (1-24) and opioids by repeated administration. Neurosci Lett 1978:9:261-266.
156. Dectcr LB. Martin LW. Lipton JM: Repeated central administration of alphα-MSH does not alter the antipyretic effect of alphα-MSH in young and aged rabbits. Peptides 1989:10: 697-699.
157. Sicgrist W. Eberle AN: Homologous regulation ofthc MSH receptor in melanoma cells. J Recepì Res 1993:13:263-281.
158. Kamcyama K, Tanaka S, Ishida Y, Hearing VJ: Interferons modulate the expression or hormone receptors on the surface of murine melanoma cells. J Clin Invest 1989:83:213-221.
159. Chakraborty AK. Orlow SJ. Pawelek JM: Stimulation of the receptor for melanocyte-stimulating hormone by retinoic acid. FEBS Lett 1990:276:205-208.
160. McLanc J, Osbcr M, Pawelek JM: Phosphorγ-latcd isomers of /.-dopa stimulate MSH binding capacity and responsiveness to MSH in cultured melanoma cells. Biochem Biophys Res Commun 1987:145:719-725.
161. Thody AJ. Hunt G. Donaticn PD. Todd C: Human melanocytes express functional melanocyte-stimulating hormone receptors. Ann NY Acad Sci 1993:680:381-390.
162. Bolognia J. Murray M. Pawelek J: UVB-induced mclanogcnesis may be mediated through the MSH-receptor system. J Invest Dermatol 1989:92:651-656.
163. Chakraborty A. Pawelek J: MSH receptors in immortalized human epidermal kcratino-cytes: A potential mechanism for coordinate regulation of the cpidcrmal-mclanin unit. J Cell Physiol 1993:157:344-350.
164. Chakraborty A, Slominski A, Ermak G, Hwang J, Pawelek J: Ultraviolet B and melanocyte-stimulating hormone (MSH) stimulate mRNA production for alpha-MSH receptors and proopiomclanocortin-dcrivcd peptides in mouse melanoma cells and transformed kcratinocytcs. J Invest Dermatol 1995:105:655-659.
165. Yamaizumi M. Mekada M. Uchida T. Okada Y: One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell 1978:15:245-250.
166. Varga JM, Moellmann G, Fritsch P, Godaw-ska E, Lerncr AB: Association of cell surface receptors for mclanotropin with the Golgi region in mouse melanoma cells. Proc Natl Acad Sci USA 1976:73:559-562.
167. Schioih HB. Kuusincn A. Muccniccc R. Sjar-dcnings M. Keinanen K. Wikberg JES: Expression of functional melanocortin 1 receptors m insect cells. Biochcm Biophys Res COmmun 1996;221:807-814.
168. Xia Y. Muccniccc R. Wikberg JES: Immunological localisation of melanocortin I receptor on the cell surface of WM266-4 human melanoma cells. Cancer Lett 1996;95: 157-162.
169. Varga JM, Dipasquale A, Pawclck J, McGuire JS, Lcmer AB: Regulation of melanocyte stimulating hormone action at the receptor level: Discontinuous binding of hormone to synchronized mouse melanoma cells during the cell cycle. Proe Natl Acad Sci USA 1974;71:1590-1593.
170. DiPasquale A, McGuire J, Varga JM: The number of receptors for P-melanocvte stimulating hormone on Cloudman melanoma cells is increased by dibutyryl adenosine cyclic monophosphate or cholera toxin. Proe Natl Acad Sci USA 1977:74:601-605.
171. Fuller BB. Brooks BA: Application of percent labeled mitoses (PLM) analysis to the investigation of melanoma cell responsiveness to MSH stimulation throughout the cell cycle. Exp Cell Res 1980:126:183-190.
172. McLane JA, Pawclck JM: Receptors for B-mclanocytc-slimulating hormone exhibit positive cooperativity in synchronized melanoma cells. Biochemistry 1988;27:3743-3747.
173. Radinsky R, Beltran PJ, Tsan R, Zhang R, Cone RD, Fidler IJ: Transcriptional induc-tion of the melanocyte-stimulating hormone receptor in brain mctastases of murine k-1735 melanoma. Cancer Res 1995:55:141-148.
174. Mountjoy KG, Bird IM, Rainey WE, Cone RD: ACTH induces up-regulation oi ACTH receptor mRNA in mouse and human adrenocortical cell lines. Mol Cell Endocrinol 1994;99:R17-R20.
175. Lcbrcthon MC. Naville D. Begeot M. Saez JM: Regulation of corticotropin receptor number and messenger RNA in cultured human adrcncortical cells by corticotropin and angiotensin 11. J Clin Invest 1994:93:1828-1833.
176. Allen RG. Carey C. Parker JD. Mortrud MT. Mellon SH. Low MJ: Targeted ablation of pituitary pre-proopiomelanocortin cells by herpes simplex virus-1 thymidine kinase differentially regulates mRNAs encoding the adrenocorticotropin receptor and aldosterone synthase in the mouse adrenal gland. Mol Endocrinol 1995:9:1005-1016.
177. Olson MF. Sehimmer BP: Heterologous dc-sensitization of the human dopamine Dl receptor in Yl adrenal cells and in a desensiti-zation-resistant Yl mutant. Mol Endocrinol 1992:6:1095-1102.
178. Olson MF. Sehimmer BP: Reccptor-G-pro-tcin coupling in desensitization-resistant mutant adrenal cells. Endocrinology 1994; 134: 7-10.
179. Druey KM, Blumer KJ, Kang VH, Kelirl JM: Inhibition of G-protein-medialcd MAP kinase activation by a new mammalian gene family. Nature 1996:379:742.
180. Sidcrovsky DP. I lessel A. Chung S. Mak TW. Tyers M; A new family of regulators of G-pro-tein coupled receptors? Curr Biol 1996:6: 211.
181. Alvaro JD, Tatro JB, Duman RS: Mclanocor-lins and opiate addiction, submitted.
182. Alvaro JD. Entwistle ML. Tatro JB. Duman RS: Chronic cocaine administration increases melanocortin 4-receptor mRNA expression in rat striatum. Soc Neurosci Abstr 1996:22: 80.
183. I S3 Mountjoy KG. Eila CJ. Williams CF., Sin-mannc ES: Melanoeortin-4 receptor (MC4-R) mRNA expression is up-regulated following hypoxic-ischemic brain injury. Proc 77th Annu Meet Endocrol Soe. Washington. 1995. p 531.
184. Resell GE, Millington WR: Glycyl-l.-gluta-minc antagonizes u-.MSI I-elicited thermogenesis. Peptides 1993:14:971-975.
185. Miller CL. llruby VJ. Matsunaga TO. Bickford PC: Alphα-MSH and MCH arc functional antagonists in a CNS auditory gating paradigm. Peptides 1993:14:431-440.
186. Al-Obeidi F. llruby VJ. Hadley ME. Sawyer TK. Castrucci AMDL: Design, synthesis, and biological activities of a potent and selective α-mclanotropin antagonist. Int J Peptide Protein Res 1990:35:228-234.
187. Sawyer TK, Staples DJ, Castrucci AML, Hadley ME: Discovery and structurc-aetivity relationships of novel u-melanocylc stimulating hormone inhibitors. Peptide Res 1989:2:140-146.
188. Sawver TK, Staples DJ, Castrucci AML, Hadley ME, Al-Obcidi FA, Cody WL, llruby VJ: u-Mclanoeytc stimulating hormone message and inhibitory sequences: Comparative slruc-lure-activity studies on melanocytes. Peptides 1990:11:351-357.
189. Castrucci AMD, Sherbrooke WC, Sawyer TK, Staples DJ, Tuma MCB, Hadley ME; Discovery of an alpha-mclalotropin antagonist effective in vivo. Peptides 1994:15:627-632.
190. Tatro JB, Entwistle ML: Identification of a specific mammalian melanocortin receptor antagonist. Ann N Y Acad Sci 1994:739:315-319.
191. Adan RAIL Oostcrom J. Ludvigsdottir G. Brakkee Jff. Burbach JPH. Gispen WH: Identification of antagonists for melanocortin MC3. MC2. and MC5 receptors. F.ur J Pharmacol 1994:269:331-337.
192. Jayawiekreme CK. Quillan JM. Graminski GF. Lerner MR: Discovery' and slructure-I unclion analysis of β-melanocyte-slimulating hormone antagonists. J Biol Chcm 1994:269: 29846-29854.
193. 10]-α-mclanocytc-stimulating hormone(4-10)-NH: with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J Med Chcm 1995:38:3454-3461.
194. Hruby VJ, Wilkes BC, Hadley ME, Al-Obcidi F, Sawyer TK, Staples DJ, de Vaux AE, Dvni O, Castrucci AML, Hinlz MF, Riehm JP, Rao KR: Alpha-mclanotropin: The minimal active sequence in the frog skin hioassay. J Med Chcm 1987:30:2126-2130.
195. Bultman SJ, Michaud FJ, Woychik RP: Molecular characterization of the mouse agouti locus. Cell 1992:71:1195-1204.
196. Eisenberg SP. Evans RJ. Arcnd WP. Verderber E. Brewer MT. Hannum CH. Thompson RC: Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990;343:341-346.
197. Miller MW, Duhl DMJ, Vrieling H, Cordes SP, Ollmann MM, Winkes BM, Barsh GS: Cloning of the mouse agomi gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev 1993:7:454-467.
198. Wilson BD, Ollmann MM, Kang L, Stoffel M, Bell GI, Barsh GS: Structure and function of ASP. the human homolog of the mouse agouti gene. Hum Mol Genet 1994:4:223-230.
199. Blanchard SO, Harris CO, Ittoop ORR, Nichols JS, Parks DJ. Trucsdalc AT, Wilkison WO: Agouti antagonism of melanocortin binding and action in the BI6FI0 murine melanoma cell line. Biochemistry 1995:34: 10406-10411.
200. Lu D, Willard D, Patel IR, Kadwcll S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkison WO, Cone RD: Agouti protein is an antagonist of the melanocytc-stimulat-ing-hormone receptor. Nature 1994:371:799.
201. Vrieling H. Duhl DMJ. Millar SE. Miller KA. Barsh GS: Differences in dorsal and ventral pigmentation result from regional expression of the mouse tigott/igene. Proc Natl Acad Sei USA 1994:91:5667-5671.
202. Yen Tf, Gill AM, Frigeri LG, Barsh GS, Wolff GL: Obesity, diabetes, and neoplasia in yellow A” * mice: Ectopic expression of the agouti gene. FASEBJ 1994;8:479-488.
203. +) mutation explained by deletion of a maternally expressed gene and the simultaneous production of agouti fusion R.NAs. Development 1994:120:1695-1708.
204. Jones BH, Kim JH, Zemel MB, Wovehik KP, Michaud EJ, Wilkison WO, Moustain N: Uprcgulation of adipocyte metabolism by agouti protein: Possible paracrine actions in yellow mouse obesity. J Am Physiol 1996: 270:E192-E196.
205. Kucera GT, Bortner DM, Rosenberg MP: Ovcrexprcssion of an agoitn cDNA in the skin of iransgenie mice recapitulates dominant coat color phenotypes of spontaneous mutants. Dev Biol 1996:173:162-173.
206. Klebig ML. Wilkinson JE. Geisler JG. Woychik RP: Ectopic expression of the agouti gene in transgenic mice causes obesity, features of ty pe II diabetes, and yellow fur. Proc Natl Acad Sei USA 1995:92:4728-4732.
207. Manne J, Argeson AC, Siracusa LD: Mechanisms for the pleiotropic effects of the agouti gene. Proc Natl Acad Sci USA 1995:92:4721-4724.
208. Willard DH, Bodnar W, Harris C. Kiefer L. Nichols JS. Blanchard S, Hoffman C, Moyer M, Burkhart W, Weiel J, Luther MA. Wilki-son WO. Rocquc WJ: Agouti structure and function: Characterization of a potent α-me-lanocyte stimulating hormone receptor antagonist. Biochemistry' 1995:34:12341-12346.
209. Zcmcl MB, Kim JH, Woychik RP. Michaud E, Kadwell SH, Patel IR, Wilkison WO; Agouti regulation of intracellular calcium: Role in the insulin resistance of viable yellow mice. Proc Natl Acad Sci USA 1995:92: 4733-4737.
210. Hunt G, Thody AJ: Agouti protein can act independently of melanocyte-stimulating hormone to inhibit melanogcnesis. J Endocrinol 1995; 147:R1-R4.
211. Cervini LA, Gray WR, Kaiser RK, Dykert J, Chan R, Solomon S, Rivier CL, Rivier JE: Rat corticostatin R4: Synthesis, disulfide bridge assignment, and in vivo activity. Peptides 1995:16:837-842.
212. Zhu Q. Solomon S: Isolation and mode of action of rabbit corticostatic (antiadrcnocor-ticotropin) peptides. Endocrinology 1992; 130:1413-1423.
213. Palkovits M, Mezey E, Eskay RL: Pro-opio-melanocortin-derived peptides (ACTH/β-en-dorphin/alphα-MSH) in brainstem barore-ceptor areas of the rat. Brain Res 1987;436: 323-328.
214. Baker H, Ruggiero DA, Aldcn S, Anwar M. Reis DJ: Anatomical evidence for interactions between catecholamine- and adrenocor-ticotropin-containing neurons. Neuroscience 1986;17:469-484.
215. Joseph SA, Pilcher WH, Knigge KM: Anatomy of the corticotropin-releasing factor and opiomelanocortin systems of the brain. Fed Proc 1985:44:100-107.
216. Dunn AJ: Effects of ACTH, β-lipotropin, and related peptides on the central nervous system; in Ncmcroff CB. Dunn AJ (eds): Peptides. Hormones, and Behavior. New York. Spectrum Publications. 1984, pp 273-347.
217. Macaluso A. McCoy D. Ceriani G. Watanabe T. Biltz J. Catania A. Lipton JM: Antiinflammatory influences of α-MSH molecules: Central neurogenic and peripheral actions. J Neu-rosci 1994;14:2377-2382.
218. Ceriani G, Macaluso A, Catania A, Lipton JM: Central neurogenic antiinflammatory' action of α-MSH: Modulation of peripheral inflammation induced by cytokines and other mediators of inflammation. Neuroendocrino-logv 1994;59:138-143.
219. Milligan ED, Green PG, Levine JD, Dallman MF: Central α-MSH effects on two models of peripheral inflammation in the rat. Soc Neu-rosci Abstr 1995;21:1155.
220. Gruber KA, Callahan MF: ACTH-(4-10) through γ-MSH: Evidence for a new class of central autonomic nervous system-regulating peptides. Am J Physiol 1989;R681-R694.
221. Bertolini A, Poggioli R, Vergoni AV: Cross-species comparison of the ACTH-induced behavioral syndrome. Ann N Y Acad Sci 1988; 525:114-129.
222. Koh HK: Cutaneous melanoma. N Engl J Med 1991;325:171-182.
223. Solca FF. Chlubα-dc Tapia J, Iwata K, Eberle AN: B16-G4F mouse melanoma cells: An MSH receptor-deficient cell clone. FEBS Lett 1993:322:177-180.
224. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH. Fang Q, Berkemcier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Bum P, Lee F: Targeted disruption of the melanocortin-4 recep-torgcne results in obesity in mice. Cell 1997; 88:131-141.